DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Call for Papers
    • Exhibition & Sponsorship Opportunities
    • Attending Exhibitors and Sponsors
    • Hotel and Travel
    • New Researcher Network Summer Event
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • ISAM Congress 2026
    • RDD 2026
  • The Aerosol Society logo
Ross Blezard

Ross Blezard

DFE Pharma

Ross serves as the Global Technical Lead for Inhalation and Biopharma Excipients at DFE Pharma GmbH, where he brings over 15 years of scientific expertise and industry insight. He holds a BSc (Hons) in Physics from the University of Surrey and after a brief foray in the defence sector, transitioned to the pharmaceutical industry in 2009.
With a deep specialization in the development and characterization of OINDPs, Ross has contributed significantly to both novel and generic product innovation via commercial research. His dedication to advancing pharmaceutical science is underscored by his active engagement as a speaker at prominent industry events.
In his current role, Ross focuses on the strategic application of excipients to support the evolution of inhaled and biologic drug delivery systems. His work reflects a commitment to shaping the future of therapeutics through cutting-edge formulation science.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk